These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 35902787)
1. Initial introduction and spread of the SARS-CoV-2 AY.4.2.1 Delta variant in Bulgaria, a genomic insight. Alexiev I; Giovanetti M; Cella E; Ivanov I; Stoikov I; Donchev D; Grigorova L; Gancheva A; Dimitrova R; Korsun N; Trifonova I; Philipova I; Dobrinov V; Grigorova I; Kantardjiev T; Christova I; Ciccozzi M J Med Virol; 2022 Dec; 94(12):6060-6064. PubMed ID: 35902787 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight. Angeletti S; Giovanetti M; Fogolari M; Cella E; De Florio L; Lintas C; Veralli R; Francesconi M; Caccuri F; De Cesaris M; De Flora C; Ceccarelli G; Spoto S; Caruso A; Pascarella S; Riva E; Ciccozzi M J Med Virol; 2022 Apr; 94(4):1689-1692. PubMed ID: 34766651 [TBL] [Abstract][Full Text] [Related]
3. Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2. Saunders N; Planas D; Bolland WH; Rodriguez C; Fourati S; Buchrieser J; Planchais C; Prot M; Staropoli I; Guivel-Benhassine F; Porrot F; Veyer D; Péré H; Robillard N; Saliba M; Baidaliuk A; Seve A; Hocqueloux L; Prazuck T; Rey FA; Mouquet H; Simon-Lorière E; Bruel T; Pawlotsky JM; Schwartz O EBioMedicine; 2022 Mar; 77():103934. PubMed ID: 35290827 [TBL] [Abstract][Full Text] [Related]
4. Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic. Focosi D; Maggi F; McConnell S; Casadevall A Future Microbiol; 2022 Mar; 17():219-221. PubMed ID: 35164530 [No Abstract] [Full Text] [Related]
5. Genomic Epidemiology and Lineage Dynamics of SARS-CoV-2 in Bulgaria: Insights from a Three-Year Pandemic Analysis. Giovanetti M; Cella E; Ivanov I; Grigorova L; Stoikov I; Donchev D; Dimitrova R; Slavov SN; Mavian C; Fonseca V; Scarpa F; Borsetti A; Korsun N; Trifonova I; Dobrinov V; Kantardjiev T; Christova I; Ciccozzi M; Alexiev I Viruses; 2023 Sep; 15(9):. PubMed ID: 37766330 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing. Mannsverk S; Bergholm J; Palanisamy N; Ellström P; Kaden R; Lindh J; Lennerstrand J Virol J; 2022 Oct; 19(1):164. PubMed ID: 36258215 [TBL] [Abstract][Full Text] [Related]
7. Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic. Umair M; Ikram A; Rehman Z; Haider SA; Ammar M; Badar N; Ali Q; Rana MS; Salman M J Med Virol; 2022 Oct; 94(10):4869-4877. PubMed ID: 35754094 [TBL] [Abstract][Full Text] [Related]
13. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern. Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323 [TBL] [Abstract][Full Text] [Related]
14. Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy. Baj A; Novazzi F; Drago Ferrante F; Genoni A; Tettamanzi E; Catanoso G; Dalla Gasperina D; Dentali F; Focosi D; Maggi F Emerg Microbes Infect; 2021 Dec; 10(1):2010-2015. PubMed ID: 34651569 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand. Sila T; Surasombatpattana S; Rajborirug S; Laochareonsuk W; Choochuen P; Kongkamol C; Ingviya T; Prompat N; Mahasirimongkol S; Sangkhathat S; Aiewsakun P Sci Rep; 2024 Apr; 14(1):7729. PubMed ID: 38565881 [TBL] [Abstract][Full Text] [Related]
16. Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka. Ranasinghe D; Jayathilaka D; Jeewandara C; Gunasinghe D; Ariyaratne D; Jayadas TTP; Kuruppu H; Wijesinghe A; Bary FF; Madhusanka D; Pushpakumara PD; Guruge D; Wijayamuni R; Ogg GS; Malavige GN Front Public Health; 2022; 10():873633. PubMed ID: 35801250 [TBL] [Abstract][Full Text] [Related]
17. [Genomics and epidemiology of SARS-CoV-2 lineage]. Sukegawa S; Takeuchi H Uirusu; 2021; 71(1):19-32. PubMed ID: 35526991 [TBL] [Abstract][Full Text] [Related]
18. Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019-2022. Sharif N; Alzahrani KJ; Ahmed SN; Khan A; Banjer HJ; Alzahrani FM; Parvez AK; Dey SK PLoS One; 2022; 17(8):e0271074. PubMed ID: 35913920 [TBL] [Abstract][Full Text] [Related]
19. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada. Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H Front Public Health; 2022; 10():915363. PubMed ID: 35859775 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 from COVID-19 Patients in the Republic of Moldova: Whole-Genome Sequencing Results. Morozov A; Nirca V; Victorova A; Poppert S; Frickmann H; Yamada C; Kacena MA; Rata S; Movila A Viruses; 2022 Oct; 14(10):. PubMed ID: 36298865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]